ArticleNano-micro letters2026
Modularly-Assembled Smart Microneedle Platform for Machine Learning-Driven Personalized Health Monitoring.
Article in Nano-micro letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Bioelectronic Considerations in Biomedical Microneedles.Small (Weinheim an der Bergstrasse, Germany) · 2026Review
- Smart wearable biosensors: a transformative synergy between diagnosis and treatment of disease.RSC advances · 2026Review
- Wearable Electronics for Precision Diagnosis Through Advanced Manufacturing and Integration.Nano-micro letters · 2026Review
- Convergence of Soft Electronics and Artificial Intelligence: From Materials to Intelligent Systems.Nano-micro letters · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Given the inherent complexity of metabolic pathways and disease-associated agents, next-generation healthcare necessitates wearable, non-invasive, and customized approaches to continuously monitor a broad spectrum of physiologically relevant biomarkers for personalized health management. Moreover, existing data-based analytical strategies remain inadequate for delivering quantitative and predictive evaluations of health status in real-life settings. Here, we report an electronic multiplexed microneedle-based biosensor patch (eMPatch) that enables real-time, minimally invasive monitoring of key metabolic biomarkers in interstitial fluid, including glucose, uric acid, cholesterol, sodium, potassium, and pH. By integrating modular microneedle (MN) sensors into a skin-interfaced flexible platform, the eMPatch achieves robust mechanical stability and seamless skin conformity, thereby ensuring reliable and continuous sensing within the dermal space. In vivo validation in animal models under metabolic intervention highlights the strong capability of the eMPatch for real-time physiological tracking across diverse daily activities. Implemented with a machine learning algorithm, the eMPatch enables automatic feature extraction and multi-task health assessment, achieving a classification accuracy of 0.996 in distinguishing normal and diet-induced metabolic disorder for health condition identification and an R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.